About FDA

Division of Oncology Products 1 (DOP1)

Director: Geoffrey Kim, M.D.
Deputy Director: Amna Ibrahim

Associate Deputy Director: Julia Beaver
Deputy Director for Safety: Katherine Fedenko 

Safety Reviewer: Michael Brave

Safety Regulatory Project Manager: Christina Marshal
Associate Director of Labeling: William Pierce

Chief Project Management Staff: Christy Cottrell
Chief Project Management Staff: Alice Kacuba

Project Specialist: Dolores Bowen

The Division of Oncology Products 1 (DOP1) regulates Investigational New Drug Applications (INDs), New Drug Applications (NDAs) and Biologic Licensing Applications (BLAs) for the following therapeutics areas:

  1. Breast Cancer
  2. Gynecologic Cancers
  3. Genitourinary Cancers
  4. Supportive care (non-hematologic) Products

Mailing Address:

Food and Drug Administration
Center for Drug Evaluation and Research
Division of Oncology Products 1 (DOP1)
5901-B Ammendale Road
Beltsville, MD 20705-1266

Phone:  (301) 796-2330
Fax: (301) 796-9845

Page Last Updated: 02/28/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English